Bioteque Corporation manufactures and sells medical devices in Asia, South America, North America, and internationally. The company provides medical disposables for use in hemodialysis access, endovascular treatment, and other fields. It also offers dialysis products, including hemodialysis bloodlines, A.V.F. needles, and hemodialysis cathers; interventional radiology products, such as pigtail drainage catheter sets, introducer sets, connecting tubes, drainage bags, and radiopaque dilators; urology products comprising ureteral stent sets and urine collection bags; and IV administration products, such as PVC IV infusion bags, PVC bags, and twist-off ports. In addition, the company provides respiratory care products, such as closed suction catheters and endotracheal tubes; vascular access products comprising angiographic catheters, PTA balloon dilatation catheters, sheath introducers, guidewires, high pressure connecting tubes, PTCA balloon dilatation catheter-rapid exchange products, manifolds, and Y connectors; and medical components, including dialyzer connectors and caps, recirculating connectors with cap, rotating luer lock connectors, pump and T connectors, injection sites, female luers, luer lock and chamber caps, drip chambers, filters, clamps, pressure pillows, safeline HDF components, chamber assembly, and transducer protectors, as well as medical masks. Bioteque Corporation was incorporated in 1991 and is headquartered in Taipei, Taiwan.
Bioteque Dividend Announcement
• Bioteque announced a annually dividend of NT$4.50 per ordinary share which will be made payable on 2024-08-30. Ex dividend date: 2024-07-30
• Bioteque annual dividend for 2024 was NT$4.50
• Bioteque annual dividend for 2023 was NT$4.50
• Bioteque's trailing twelve-month (TTM) dividend yield is 3.6%
• Bioteque's payout ratio for the trailing twelve months (TTM) is 62.19%
• Bioteque's dividend growth over the last five years (2018-2023) was 5.15% year
• Bioteque's dividend growth over the last ten years (2013-2023) was 11.04% year
Bioteque Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-07-30 | NT$4.50 | annually | 2024-08-30 |
2023-08-30 | NT$4.50 | annually | 2023-09-28 |
2022-08-31 | NT$4.50 | annually | 2022-09-29 |
2021-08-31 | NT$4.00 | annually | 2021-09-29 |
2020-08-26 | NT$4.00 | annually | 2020-09-28 |
2019-08-29 | NT$4.00 | annually | 2019-09-26 |
2018-08-30 | NT$3.50 | annually | 2018-09-21 |
2017-08-29 | NT$2.00 | annually | 2017-09-27 |
2016-08-25 | NT$2.60 | annually | |
2015-09-24 | NT$2.61 | annually | |
2014-08-28 | NT$1.77 | annually | |
2013-08-28 | NT$1.58 | annually |
Bioteque Dividend per year
Bioteque Dividend growth
Bioteque Dividend Yield
Bioteque current trailing twelve-month (TTM) dividend yield is 3.6%. Interested in purchasing Bioteque stock? Use our calculator to estimate your expected dividend yield:
Bioteque Financial Ratios
Bioteque Dividend FAQ
Other factors to consider when evaluating Bioteque as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Bioteque stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Bioteque's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Bioteque publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Bioteque distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Bioteque are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Bioteque sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Bioteque distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Bioteque declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Bioteque's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Bioteque's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.